PA
KROS icon

Profund Advisors’s Keros Therapeutics KROS Stock Holding History

Profund Advisors’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,483
Closed -$234K – 1203
2025
Q4 		$234K Buy
+11,483
New +$201K 0.01% 1065
2025
Q3 		– Sell
-11,421
Closed -$152K – 1072
2025
Q2 		$152K Sell
11,421
-148
-1% -$2K 0.01% 939
2025
Q1 		$118K Buy
+11,569
New +$134K 0.01% 938
2024
Q4 		– Sell
-8,392
Closed -$487K – 1156
2024
Q3 		$487K Sell
8,392
-2,415
-22% -$119K 0.02% 545
2024
Q2 		$494K Sell
10,807
-7,854
-42% -$422K 0.02% 500
2024
Q1 		$1.24M Buy
18,661
+7,814
+72% +$463K 0.05% 303
2023
Q4 		$431K Buy
10,847
+826
+8% +$25.9K 0.02% 592
2023
Q3 		$319K Sell
10,021
-2,914
-23% -$109K 0.02% 641
2023
Q2 		$520K Buy
12,935
+1,091
+9% +$47.8K 0.03% 501
2023
Q1 		$506K Buy
+11,844
New +$598K 0.03% 498

Other funds holding KROS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return